Weight Regain

Weight Regain

Weight regain is one of the biggest challenges in obesity treatment. It happens to most people who achieve meaningful weight loss, whether through lifestyle change, medication or even bariatric surgery. After weight loss, the body mounts a coordinated pushback aimed at restoring its energy reserves to the old set point. Resting metabolic rate falls (metabolic adaptation), hunger hormones such as ghrelin rise, fullness hormones such as leptin and GLP-1 fall, and the brain’s reward response to food cues grows stronger. All of this can last for months or years after weight loss.

Data from GLP-1 receptor agonist trials show that weight returns quickly once treatment stops. In the STEP 1 extension with semaglutide, participants regained about two-thirds of the weight they had lost within one year of stopping. This underlines that obesity is a chronic, relapsing disease and supports long-term medication to keep weight off, just as long-term medication is accepted for hypertension or high cholesterol.

For retatrutide, what happens after stopping is still an important open question. In the Phase 2 obesity trial, weight loss was still speeding up at 48 weeks in the higher dose groups, which suggests weight had not yet stabilized. Knowing how weight returns after stopping retatrutide, and whether lower maintenance doses can hold the loss, will be critical for planning long-term treatment. Extension studies and dedicated maintenance trials within the wider TRIUMPH program are expected to address these questions.